UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$767M |
| 2 |
Amazon
AMZN
|
+$288M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$287M |
| 4 |
NVIDIA
NVDA
|
+$259M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$316M |
| 3 |
Citigroup
C
|
+$269M |
| 4 |
Charter Communications
CHTR
|
+$229M |
| 5 |
NetEase
NTES
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 12.19% |
| 4 | Healthcare | 12.04% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVRI
1826
DELISTED
Everi Holdings
EVRI
| $1.49M | ﹤0.01% |
105,484
| – | – |
|
|
SAND
1827
DELISTED
Sandstorm Gold
SAND
| $1.48M | ﹤0.01% |
218,788
| – | – |
|
|
CSII
1828
DELISTED
Cardiovascular Systems, Inc.
CSII
| $1.48M | ﹤0.01% |
38,696
+802
| +2% | +$34.1K |
|
1829
Seres Therapeutics
MCRB
$48.9M
| $1.48M | ﹤0.01% |
3,601
+449
| +14% | +$207K |
|
1830
Gates Industrial Corporation Ltd.
GTES
$7.15B
| $1.48M | ﹤0.01% |
92,710
+18,740
| +25% | +$290K |
|
1831
Caleres
CAL
$487M
| $1.48M | ﹤0.01% |
+67,912
| New | +$1.16M |
|
|
RWT
1832
Redwood Trust
RWT
$594M
| $1.48M | ﹤0.01% |
142,200
-10,428
| -7% | -$100K |
|
1833
Triumph Financial Inc
TFIN
$1.82B
| $1.48M | ﹤0.01% |
19,099
+1,052
| +6% | +$73.2K |
|
|
TUP
1834
DELISTED
Tupperware Brands Corporation
TUP
| $1.48M | ﹤0.01% |
55,856
+2,621
| +5% | +$81.6K |
|
1835
Cytokinetics
CYTK
$10.4B
| $1.48M | ﹤0.01% |
63,417
+9,842
| +18% | +$210K |
|
1836
Community Health Systems
CYH
$423M
| $1.47M | ﹤0.01% |
108,761
+15,654
| +17% | +$154K |
|
|
WW
1837
DELISTED
WW International
WW
| $1.47M | ﹤0.01% |
46,975
-4,300
| -8% | -$124K |
|
1838
Cohen & Steers
CNS
$4.3B
| $1.46M | ﹤0.01% |
22,424
-3,805
| -15% | -$260K |
|
1839
SelectQuote
SLQT
$121M
| $1.46M | ﹤0.01% |
49,601
+38,101
| +331% | +$999K |
|
1840
Calix
CALX
$2.39B
| $1.46M | ﹤0.01% |
42,213
+2,312
| +6% | +$85.6K |
|
1841
Verra Mobility
VRRM
$744M
| $1.46M | ﹤0.01% |
107,574
-4,421
| -4% | -$61.3K |
|
1842
M/I Homes
MHO
$3.84B
| $1.45M | ﹤0.01% |
24,608
-1,564
| -6% | -$81.2K |
|
1843
Beam Therapeutics
BEAM
$2.84B
| $1.45M | ﹤0.01% |
18,151
+5,113
| +39% | +$486K |
|
1844
Diageo
DEO
$53.6B
| $1.45M | ﹤0.01% |
8,828
+2,610
| +42% | +$427K |
|
1845
Virtus Investment Partners
VRTS
$1.1B
| $1.45M | ﹤0.01% |
6,137
-538
| -8% | -$129K |
|
1846
Clean Energy Fuels
CLNE
$346M
| $1.44M | ﹤0.01% |
105,049
-22,014
| -17% | -$282K |
|
|
DCH
1847
Dauch Corp
DCH
$1.51B
| $1.44M | ﹤0.01% |
148,694
-32,902
| -18% | -$326K |
|
1848
iShares MSCI China A ETF
CNYA
$208M
| $1.44M | ﹤0.01% |
+34,900
| New | +$1.55M |
|
|
SWTX
1849
DELISTED
SpringWorks Therapeutics
SWTX
| $1.43M | ﹤0.01% |
19,400
+3,800
| +24% | +$298K |
|
1850
ePlus
PLUS
$2.34B
| $1.43M | ﹤0.01% |
28,642
| – | – |
|
Similar funds
UBS AM's Q1 2021 Portfolio in Review
As of Q1 2021, UBS AM held 2,645 positions worth $226B, up 6% from $213B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 4.9%. UBS AM opened 86 new positions and exited 44, leaving the 2,645-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS AM's largest Q1 2021 buy was Seagen Inc. Common Stock: 966,114 shares worth $134M.
- UBS AM added most to Infosys in Q1 2021, an estimated $767M increase.
- UBS AM's biggest Q1 2021 reduction was Alibaba, cutting an estimated $347M.
- UBS AM fully exited Lumen in Q1 2021, selling an estimated $45.5M.
- UBS AM's ten largest holdings make up 22% of its $226B portfolio in Q1 2021.
- UBS AM opened 86 new positions and closed 44 in Q1 2021.
- UBS AM's portfolio value rose 6% quarter-over-quarter to $226B.
Based on UBS AM's 13F filing for Q1 2021, filed 14 May 2021.